Cargando…

Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis

Myxovirus A (MxA), a protein encoded by the MX1 gene with antiviral activity, has proven to be a sensitive measure of IFNβ bioactivity in multiple sclerosis (MS). However, the use of MxA as a biomarker of IFNβ bioactivity has been criticized for the lack of evidence of its role on disease pathogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malhotra, Sunny, Bustamante, Marta F., Pérez-Miralles, Francisco, Rio, Jordi, Ruiz de Villa, Mari Carmen, Vegas, Esteban, Nonell, Lara, Deisenhammer, Florian, Fissolo, Nicolás, Nurtdinov, Ramil N., Montalban, Xavier, Comabella, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160307/ https://www.ncbi.nlm.nih.gov/pubmed/21886806 http://dx.doi.org/10.1371/journal.pone.0023634

Ejemplares similares

Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta
por: Bustamante, Marta F., et al.
Publicado: (2013)

Treatment with MOG-DNA vaccines induces CD4(+)CD25(+)FoxP3(+) regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis
por: Fissolo, Nicolás, et al.
Publicado: (2012)

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015)

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
por: Malhotra, Sunny, et al.
Publicado: (2018)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure
por: Malhotra, Sunny, et al.
Publicado: (2023)

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
por: Bustamante, Marta F., et al.
Publicado: (2015)

Liquid Biopsy in Neurological Diseases
por: Malhotra, Sunny, et al.
Publicado: (2023)

Immunomodulatory Effects Associated with Cladribine Treatment
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods
por: Baranzini, Sergio E, et al.
Publicado: (2005)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms
por: Comabella, Manuel, et al.
Publicado: (2008)

Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple Sclerosis
por: Martínez-Barriocanal, Águeda, et al.
Publicado: (2017)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
por: Tur, Carmen, et al.
Publicado: (2013)

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course
por: Gil-Varea, Elia, et al.
Publicado: (2018)

Lesion topographies in multiple sclerosis diagnosis: A reappraisal
por: Arrambide, Georgina, et al.
Publicado: (2017)

Fast rate of evolution in alternatively spliced coding regions of mammalian genes
por: Ermakova, Ekaterina O, et al.
Publicado: (2006)

Rodent-specific alternative exons are more frequent in rapidly evolving genes and in paralogs
por: Nurtdinov, Ramil N, et al.
Publicado: (2009)

Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis
por: Ortiz, Miguel A., et al.
Publicado: (2015)

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
por: Link, Jenny, et al.
Publicado: (2017)

No statistical support for correlation between the positions of protein interaction sites and alternatively spliced regions
por: Offman, Marc N, et al.
Publicado: (2004)

Optic Nerve Topography in Multiple Sclerosis Diagnosis: The Utility of Visual Evoked Potentials
por: Vidal-Jordana, Angela, et al.
Publicado: (2021)

Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles
por: de la Hera, Belén, et al.
Publicado: (2014)

PLANdbAffy: probe-level annotation database for Affymetrix expression microarrays
por: Nurtdinov, Ramil N., et al.
Publicado: (2010)

Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
por: Hegen, Harald, et al.
Publicado: (2016)

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI
por: Coll, Llucia, et al.
Publicado: (2023)

Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis
por: Zuluaga, María I., et al.
Publicado: (2019)

Ancient and Recent Selective Pressures Shaped Genetic Diversity at AIM2-Like Nucleic Acid Sensors
por: Cagliani, Rachele, et al.
Publicado: (2014)

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis
por: Cantó, Ester, et al.
Publicado: (2014)

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS
por: Fissolo, Nicolás, et al.
Publicado: (2021)

A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
por: Gil-Varea, Elia, et al.
Publicado: (2020)

Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
por: Mena, Jorge, et al.
Publicado: (2022)

Therapeutic Inertia in the New Landscape of Multiple Sclerosis Care
por: Saposnik, Gustavo, et al.
Publicado: (2018)

Conserved and species-specific alternative splicing in mammalian genomes
por: Nurtdinov, Ramil N, et al.
Publicado: (2007)

Multiple sclerosis and nutrition: back to the future?
por: Gold, Ralf, et al.
Publicado: (2020)

Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis
por: Carrión, Belinda, et al.
Publicado: (2021)

Metabolomic signatures associated with disease severity in multiple sclerosis
por: Villoslada, Pablo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8koj9f5n9k9b9rihuuoe1soqke